Index by author

01 January 2010; volume 35, issue 1

A

  1. Abitbol, V.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  2. Aine, T.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  3. Allanore, Y.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  4. Anders, S.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  5. Anderson, P. B.

    1. Thompson, A. A. R. et al "A complication of peroral bronchoscopy." European Respiratory Journal 35.1 (2010): 221-222. Web. 27 Feb. 2021.

  6. Annila, I.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  7. Arellano-Orden, E.

    1. Montes-Worboys, A. et al "Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis." European Respiratory Journal 35.1 (2010): 160-166. Web. 27 Feb. 2021.

  8. Armstrong, J. J.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

B

  1. Barr, J. J.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  2. Bateman, E. D.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  3. Becker, S.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  4. Behr, J.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  5. Biardel, S.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  6. Bilderback, A. L.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  7. Bisson, A.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  8. Boehler, A.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  9. Bonetti, F.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  10. Bonniaud, P.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  11. Bottema, R. W. B.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  12. Boulet, L-P.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  13. Bowman, R. V.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  14. Boyce, D.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  15. Brain, J. D.

    1. Brain, J. D., W. Kreyling, and P. Gehr. " To the Editors: ." European Respiratory Journal 35.1 (2010): 226-227. Web. 27 Feb. 2021.

  16. Brauner, M.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  17. Breyer, M-K.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  18. Brown, K. K.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  19. Brunekreef, B.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  20. Bueso, M.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  21. Burghuber, O. C.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  22. Bush, A.

    1. Bush, A., and M. Zach. "Medicines for children in Europe: from proposals to practicalities." European Respiratory Journal 35.1 (2010): 228-229. Web. 27 Feb. 2021.

C

  1. Calabrò, E.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  2. Campo, A.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  3. Camus, P.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  4. Caspi, A.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  5. Cassandro, R.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  6. Chakir, J.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  7. Champion, H. C.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  8. Chaussade, S.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  9. Chen, L.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  10. Chien, Y-J.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  11. Colosimo, M. L.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  12. Cordier, J-F.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.

  13. Cordier, J. F.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  14. Costabel, U.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  15. Costy-Bennett, S.

    1. Rice, A. et al "Control of breathing in children with mild sleep apnoea: a 6-year follow-up study." European Respiratory Journal 35.1 (2010): 124-131. Web. 27 Feb. 2021.

  16. Cottin, V.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.
    2. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  17. Couderc, L. J.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  18. Curatolo, A.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

D

  1. Decologne, N.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  2. Demedts, I. K.

    1. Demedts, I. K., K. Y. Vermaelen, and J. P. van Meerbeeck. "Treatment of extensive-stage small cell lung carcinoma: current status and future prospects." European Respiratory Journal 35.1 (2010): 202-215. Web. 27 Feb. 2021.

  3. Dheda, K.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  4. Didon, L.

    1. Didon, L. et al "Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD." European Respiratory Journal 35.1 (2010): 186-197. Web. 27 Feb. 2021.

  5. Digón-Pereiras, J.

    1. Montes-Worboys, A. et al "Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis." European Respiratory Journal 35.1 (2010): 160-166. Web. 27 Feb. 2021.

  6. Dinh-Xuan, A. T.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  7. Dorfmüller, P.

    1. Dorfmüller, P., D. Montani, and M. Humbert. "Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension." European Respiratory Journal 35.1 (2010): 6-8. Web. 27 Feb. 2021.

  8. Draganovici, D.

    1. Geleff, S. et al "The role of chemokine receptors in acute lung allograft rejection." European Respiratory Journal 35.1 (2010): 167-175. Web. 27 Feb. 2021.

  9. Du, X.

    1. Song, Y., X. Li, and X. Du. " From the authors: ." European Respiratory Journal 35.1 (2010): 225-226. Web. 27 Feb. 2021.

  10. du Bois, R. M.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  11. Dusser, D.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

E

  1. Eastwood, P. R.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  2. Edelmann, G.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  3. Elmberger, G. P.

    1. Didon, L. et al "Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD." European Respiratory Journal 35.1 (2010): 186-197. Web. 27 Feb. 2021.

  4. Ely, M.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

F

  1. Fong, K. M.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  2. Forfia, P. R.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  3. Fregosi, R. F.

    1. Rice, A. et al "Control of breathing in children with mild sleep apnoea: a 6-year follow-up study." European Respiratory Journal 35.1 (2010): 124-131. Web. 27 Feb. 2021.

  4. Funk, G-C.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

G

  1. Garrido, C.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  2. Gehr, P.

    1. Brain, J. D., W. Kreyling, and P. Gehr. " To the Editors: ." European Respiratory Journal 35.1 (2010): 226-227. Web. 27 Feb. 2021.

  3. Geleff, S.

    1. Geleff, S. et al "The role of chemokine receptors in acute lung allograft rejection." European Respiratory Journal 35.1 (2010): 167-175. Web. 27 Feb. 2021.

  4. Gilson, M.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  5. Girgis, R. E.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  6. Gonzalez, F. J.

    1. Didon, L. et al "Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD." European Respiratory Journal 35.1 (2010): 186-197. Web. 27 Feb. 2021.

  7. Goodwin, J. L.

    1. Rice, A. et al "Control of breathing in children with mild sleep apnoea: a 6-year follow-up study." European Respiratory Journal 35.1 (2010): 124-131. Web. 27 Feb. 2021.

  8. Goudot, B.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  9. Greene, J. M.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

H

  1. Hancox, R. J.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  2. Harari, S.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.
    2. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  3. Hargreave, F. E.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  4. Hartl, S.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  5. Hassoun, P. M.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  6. Heindl, W.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  7. Hillman, D. R.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  8. Hinterholzer, G.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  9. Hollams, E.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

  10. Holt, P. G.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

  11. Hoogendoorn, M.

    1. Hoogendoorn, M. et al "Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?." European Respiratory Journal 35.1 (2010): 79-87. Web. 27 Feb. 2021.

  12. Housten, T.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  13. Humbert, M.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.
    2. Dorfmüller, P., D. Montani, and M. Humbert. "Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension." European Respiratory Journal 35.1 (2010): 6-8. Web. 27 Feb. 2021.

  14. Hummers, L. K.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

I

  1. Inoue, K.

    1. Inoue, K., and H. Takano. "Effects of nanoparticles on lung damage in humans." European Respiratory Journal 35.1 (2010): 224-225. Web. 27 Feb. 2021.

  2. Ip, M. S. M.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

J

  1. Jaksch, P.

    1. Geleff, S. et al "The role of chemokine receptors in acute lung allograft rejection." European Respiratory Journal 35.1 (2010): 167-175. Web. 27 Feb. 2021.

  2. Jayaram, L.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  3. Johnson, S. R.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

K

  1. Kahan, A.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  2. Kankaanranta, H.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  3. Kerkhof, M.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  4. King, T. E.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  5. Kingswood, C.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  6. Kohansal, R.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  7. Kolb, M.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  8. Koppelman, G. H.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  9. Kreyling, W.

    1. Brain, J. D., W. Kreyling, and P. Gehr. " To the Editors: ." European Respiratory Journal 35.1 (2010): 226-227. Web. 27 Feb. 2021.

  10. Krishnan, J. A.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

L

  1. Lai, A. Y. K.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  2. Lam, B.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  3. Lam, J. C. M.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  4. Lam, K. S. L.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  5. Langleben, D.

    1. Orfanos, S. E., and D. Langleben. "Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?." European Respiratory Journal 35.1 (2010): 223-224. Web. 27 Feb. 2021.

  6. Larsen, J. E.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  7. La Vecchia, C.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  8. Laviolette, M.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  9. Lazor, R.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  10. Lechtzin, N.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  11. Leconte, I.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  12. Lee, C-H.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  13. Lee, L-N.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  14. Legmann, P.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  15. Lehtimäki, L.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  16. Leitão, F. S.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  17. Le Pavec, J.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.
    2. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  18. Leung, C. C.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  19. Li, X.

    1. Song, Y., X. Li, and X. Du. " From the authors: ." European Respiratory Journal 35.1 (2010): 225-226. Web. 27 Feb. 2021.

  20. Lim, C-S.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  21. Lorenzi-Filho, G.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  22. Loubaki, L.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

M

  1. Machado, M-C. L.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  2. Mal, H.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.

  3. Marchianò, A.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  4. Margetts, P.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  5. Martínez-Olondris, P.

    1. Martínez-Olondris, P., M. Rigol, and A. Torres. "What lessons have been learnt from animal models of MRSA in the lung?." European Respiratory Journal 35.1 (2010): 198-201. Web. 27 Feb. 2021.

  6. Mathai, S. C.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  7. McLachlan, C. R.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  8. McLachlan, R. E.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  9. McLaughlin, R. A.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  10. Milot, J.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  11. Mitchell, H. W.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  12. Moffitt, T. E.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  13. Moilanen, E.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  14. Montani, D.

    1. Dorfmüller, P., D. Montani, and M. Humbert. "Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension." European Respiratory Journal 35.1 (2010): 6-8. Web. 27 Feb. 2021.

  15. Montes-Worboys, A.

    1. Montes-Worboys, A. et al "Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis." European Respiratory Journal 35.1 (2010): 160-166. Web. 27 Feb. 2021.

  16. Munson, J. C.

    1. Munson, J. C.. "Combined pulmonary fibrosis and emphysema: a high-pressure situation." European Respiratory Journal 35.1 (2010): 9-11. Web. 27 Feb. 2021.

  17. Murchison, J.

    1. Seville, R. A., J. Murchison, and R. L. Riha. "An unusual cause of blindness." European Respiratory Journal 35.1 (2010): 216-217. Web. 27 Feb. 2021.

N

  1. Nair, P.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  2. Nieminen, R.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  3. Noble, P. B.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  4. Noffsinger, W. J.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  5. Nord, M.

    1. Didon, L. et al "Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD." European Respiratory Journal 35.1 (2010): 186-197. Web. 27 Feb. 2021.

O

  1. Oliveira, M-V. C.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  2. Ooi, C. G.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  3. Orfanos, S. E.

    1. Orfanos, S. E., and D. Langleben. "Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy?." European Respiratory Journal 35.1 (2010): 223-224. Web. 27 Feb. 2021.

P

  1. Pai, M.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  2. Pastorino, U.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  3. Phillips, M. J.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  4. Pirzada, O. M.

    1. Thompson, A. A. R. et al "A complication of peroral bronchoscopy." European Respiratory Journal 35.1 (2010): 221-222. Web. 27 Feb. 2021.

  5. Pizzichini, E.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  6. Pizzichini, M.

    1. Chakir, J. et al "Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study." European Respiratory Journal 35.1 (2010): 48-53. Web. 27 Feb. 2021.

  7. Popper, H.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  8. Postma, D. S.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  9. Poulton, R.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  10. Prévot, G.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.

Q

  1. Quan, S. F.

    1. Rice, A. et al "Control of breathing in children with mild sleep apnoea: a 6-year follow-up study." European Respiratory Journal 35.1 (2010): 124-131. Web. 27 Feb. 2021.

  2. Queiroga, F.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

R

  1. Raghu, G.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  2. Raistrick, C. S.

    1. Thompson, A. A. R. et al "A complication of peroral bronchoscopy." European Respiratory Journal 35.1 (2010): 221-222. Web. 27 Feb. 2021.

  3. Randi, G.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  4. Reijmerink, N. E.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  5. Reynaud-Gaubert, M.

    1. Johnson, S. R. et al "European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis." European Respiratory Journal 35.1 (2010): 14-26. Web. 27 Feb. 2021.

  6. Rice, A.

    1. Rice, A. et al "Control of breathing in children with mild sleep apnoea: a 6-year follow-up study." European Respiratory Journal 35.1 (2010): 124-131. Web. 27 Feb. 2021.

  7. Rigol, M.

    1. Martínez-Olondris, P., M. Rigol, and A. Torres. "What lessons have been learnt from animal models of MRSA in the lung?." European Respiratory Journal 35.1 (2010): 198-201. Web. 27 Feb. 2021.

  8. Riha, R. L.

    1. Seville, R. A., J. Murchison, and R. L. Riha. "An unusual cause of blindness." European Respiratory Journal 35.1 (2010): 216-217. Web. 27 Feb. 2021.

  9. Rivaud, E.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  10. Rodriguez-Panadero, F.

    1. Montes-Worboys, A. et al "Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis." European Respiratory Journal 35.1 (2010): 160-166. Web. 27 Feb. 2021.

  11. Rodriguez-Portal, J. A.

    1. Montes-Worboys, A. et al "Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis." European Respiratory Journal 35.1 (2010): 160-166. Web. 27 Feb. 2021.

  12. Roos, A. B.

    1. Didon, L. et al "Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD." European Respiratory Journal 35.1 (2010): 186-197. Web. 27 Feb. 2021.

  13. Roponen, M.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

  14. Roux, S.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

  15. Rutten-van Mölken, M. P. M. H.

    1. Hoogendoorn, M. et al "Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?." European Respiratory Journal 35.1 (2010): 79-87. Web. 27 Feb. 2021.

S

  1. Saarelainen, S.

    1. Lehtimäki, L. et al "Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD." European Respiratory Journal 35.1 (2010): 72-78. Web. 27 Feb. 2021.

  2. Sampson, D. D.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  3. Schols, A. M.

    1. Hoogendoorn, M. et al "Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?." European Respiratory Journal 35.1 (2010): 79-87. Web. 27 Feb. 2021.

  4. Schuster, R.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  5. Schwarzmaier-D'Assie, A.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  6. Sears, M. R.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  7. Segerer, S.

    1. Geleff, S. et al "The role of chemokine receptors in acute lung allograft rejection." European Respiratory Journal 35.1 (2010): 167-175. Web. 27 Feb. 2021.

  8. Seville, R. A.

    1. Seville, R. A., J. Murchison, and R. L. Riha. "An unusual cause of blindness." European Respiratory Journal 35.1 (2010): 216-217. Web. 27 Feb. 2021.

  9. Shi, W.

    1. Shi, W., and D. Warburton. "Is COPD in adulthood really so far removed from early development?." European Respiratory Journal 35.1 (2010): 12-13. Web. 27 Feb. 2021.

  10. Siafakas, N. M.

    1. Siafakas, N. M.. "The European Respiratory Society, 1990–2010: a 20-year anniversary story of success." European Respiratory Journal 35.1 (2010): 1-2. Web. 27 Feb. 2021.

  11. Simonneau, G.

    1. Cottin, V. et al "Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome." European Respiratory Journal 35.1 (2010): 105-111. Web. 27 Feb. 2021.

  12. Sly, P. D.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

  13. Smit, H. A.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  14. Song, Y.

    1. Song, Y., X. Li, and X. Du. " From the authors: ." European Respiratory Journal 35.1 (2010): 225-226. Web. 27 Feb. 2021.

  15. Stelma, F. F.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  16. Sverzellati, N.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  17. Swigris, J.

    1. Raghu, G. et al "Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)." European Respiratory Journal 35.1 (2010): 118-123. Web. 27 Feb. 2021.

T

  1. Takano, H.

    1. Inoue, K., and H. Takano. "Effects of nanoparticles on lung damage in humans." European Respiratory Journal 35.1 (2010): 224-225. Web. 27 Feb. 2021.

  2. Tam, S.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  3. Tashkin, D. P.

    1. Tashkin, D. P.. "Does cannabis use predispose to chronic airflow obstruction?." European Respiratory Journal 35.1 (2010): 3-5. Web. 27 Feb. 2021.

  4. Taylor, D. R.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  5. Tcherakian, C.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  6. Thijs, C.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  7. Thompson, A. A. R.

    1. Thompson, A. A. R. et al "A complication of peroral bronchoscopy." European Respiratory Journal 35.1 (2010): 221-222. Web. 27 Feb. 2021.

  8. Togeiro, S. M.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

  9. Torres, A.

    1. Martínez-Olondris, P., M. Rigol, and A. Torres. "What lessons have been learnt from animal models of MRSA in the lung?." European Respiratory Journal 35.1 (2010): 198-201. Web. 27 Feb. 2021.

U

  1. Upham, J. W.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

V

  1. Valentin, A.

    1. Funk, G-C. et al "Incidence and outcome of weaning from mechanical ventilation according to new categories." European Respiratory Journal 35.1 (2010): 88-94. Web. 27 Feb. 2021.

  2. van Meerbeeck, J. P.

    1. Demedts, I. K., K. Y. Vermaelen, and J. P. van Meerbeeck. "Treatment of extensive-stage small cell lung carcinoma: current status and future prospects." European Respiratory Journal 35.1 (2010): 202-215. Web. 27 Feb. 2021.

  3. van Schayck, C. P.

    1. Bottema, R. W. B. et al "Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE." European Respiratory Journal 35.1 (2010): 54-63. Web. 27 Feb. 2021.

  4. van Wetering, C. R.

    1. Hoogendoorn, M. et al "Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective?." European Respiratory Journal 35.1 (2010): 79-87. Web. 27 Feb. 2021.

  5. van Zyl Smit, R. N.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  6. Vermaelen, K. Y.

    1. Demedts, I. K., K. Y. Vermaelen, and J. P. van Meerbeeck. "Treatment of extensive-stage small cell lung carcinoma: current status and future prospects." European Respiratory Journal 35.1 (2010): 202-215. Web. 27 Feb. 2021.

  7. Villani, M.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  8. Vinatier, I.

    1. Vinatier, I. et al "Nonthrombotic pulmonary embolism." European Respiratory Journal 35.1 (2010): 224. Web. 27 Feb. 2021.

  9. Vollmer, W. M.

    1. Machado, M-C. L. et al "CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD." European Respiratory Journal 35.1 (2010): 132-137. Web. 27 Feb. 2021.

W

  1. Wang, J-Y.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  2. Warburton, D.

    1. Shi, W., and D. Warburton. "Is COPD in adulthood really so far removed from early development?." European Respiratory Journal 35.1 (2010): 12-13. Web. 27 Feb. 2021.

  3. Welch, D.

    1. Hancox, R. J. et al "Effects of cannabis on lung function: a population-based cohort study." European Respiratory Journal 35.1 (2010): 42-47. Web. 27 Feb. 2021.

  4. West, A. R.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  5. Wettstein, G.

    1. Decologne, N. et al "Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles." European Respiratory Journal 35.1 (2010): 176-185. Web. 27 Feb. 2021.

  6. Wigley, F. M.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  7. Williamson, J. P.

    1. Williamson, J. P. et al "Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography." European Respiratory Journal 35.1 (2010): 34-41. Web. 27 Feb. 2021.

  8. Wipff, J.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  9. Wright, C. M.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

Y

  1. Yang, I. A.

    1. Wright, C. M. et al "Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer." European Respiratory Journal 35.1 (2010): 152-159. Web. 27 Feb. 2021.

  2. Yang, P-C.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

  3. Yao, T. J.

    1. Lam, J. C. M. et al "A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea." European Respiratory Journal 35.1 (2010): 138-145. Web. 27 Feb. 2021.

  4. Yerkovich, S. T.

    1. Roponen, M. et al "Toll-like receptor 7 function is reduced in adolescents with asthma." European Respiratory Journal 35.1 (2010): 64-71. Web. 27 Feb. 2021.

  5. Yew, W. W.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.

  6. Yu, C-J.

    1. Lim, C-S. et al "Culture result of smear-positive sputum samples after 2 months of antituberculous treatment." European Respiratory Journal 35.1 (2010): 218-220. Web. 27 Feb. 2021.

Z

  1. Zach, M.

    1. Bush, A., and M. Zach. "Medicines for children in Europe: from proposals to practicalities." European Respiratory Journal 35.1 (2010): 228-229. Web. 27 Feb. 2021.

  2. Zaiman, A. L.

    1. Mathai, S. C. et al "Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension." European Respiratory Journal 35.1 (2010): 95-104. Web. 27 Feb. 2021.

  3. Zerkak, D.

    1. Gilson, M. et al "Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases." European Respiratory Journal 35.1 (2010): 112-117. Web. 27 Feb. 2021.

  4. Zompatori, M.

    1. Calabrò, E. et al "Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes." European Respiratory Journal 35.1 (2010): 146-151. Web. 27 Feb. 2021.

  5. Zumla, A.

    1. van Zyl Smit, R. N. et al "Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD." European Respiratory Journal 35.1 (2010): 27-33. Web. 27 Feb. 2021.
Back to top
European Respiratory Journal: 35 (1)

Search Within This Issue

Jump to

Manage Table of content Alerts